🧪 As part of #ShadowDay, LIOS welcomed 48 curious students from 13 Latvian cities! They explored real career paths by shadowing professionals. In biotech, 2 students dove into research & protein structures via #PHOTOTHERAPORT
✨ For World Epilepsy Day, imagine turning seizures off with light...
EU project #PHOTOTHERAPORT combines tiny implants + photoswitchable drugs to modulate overactive neurons in real time, opening a new frontier in epilepsy therapy💡💜
#EpilepsyAwarenessDay #NeuroInnovation
Yesterday, the #Phototheraport team had the opportunity to participate in #NitRecerCat25 at the workshop “What are photodrugs & how light can help health” led by Bia Moreno & Nayeli Pérez 🌟💡
💡 Imagine tiny “light bulbs” inside your body that activate medicine only where needed!
Join #PhotoTheraport at #NitRecerCat25 for the workshop: What are photodrugs & how light can help health
📍 Casa Golferichs | 🕕 18:00 - 23/09 | Registration required
👉Last week #PHOTOTHERAPORT team met at
@IBECBarcelona for our 18-month project meeting. 2 days of intense and fruitful discussions to define next steps in our #photopharmacology strategy: light-emitting implants + photo-controlled drugs to treat #neuropathicpain & #epilepsy. 💡🧠
#EUeic #EUResearch
🧠 💡
#PHOTOTHERAPORT researchers from @ibecbarcelona.eu
and #IIBBCSIC were at #FestaDeLaCiència! About 200 assistants explored how light-emitting implants & photo-controlled drugs can precisely transform pain & epilepsy treatment. How cool is that?
#ScienceFestival #Neuroscience
On #NationalEpilepsyDay, we celebrate projects like #PHOTOTHERAPORT that, through photopharmacology, are paving the way for more precise and safer epilepsy treatments. Science in the service of health! 💡🧠
💡🧠Tomorrow is the Spanish Epilepsy Day! We want to highlight how #PHOTOTHERAPORT #EUfunded project is pioneering #photopharmacology to develop light-controlled therapies that target #Epilepsy with precision, aiming for more effective and safer treatments #epilepsia #DíaNacionalEpilepsia #EUScience
💡It’s #InternationalDayOfLight! Let’s celebrate with #PHOTOTHERAPORT, an EU project creating smart implants using light to treat pain, epilepsy & more. Precision light-based therapies are here to transform lives.
Learn more:🌐https://phototheraport.org #LightTherapy #ScienceForAll
@ibecbarcelona.eu
Shapla Bhattacharya in the center, Dmitrijs Punte in the left and Daniele Gasparini in the right
This year, #PHOTOTHERAPORT 🔬✨ participated in #ShadowDay in Latvia. Shapla, a Ph.D. student at LIOS, shadowed Dimitrijs Punte and introduced him to the fundamentals of structural biology, crystallography, and PET degradation. A fantastic opportunity to explore new professions! 🤝
@ibecbarcelona.eu
🔬💡 Last week #PHOTOTHERAPORT researchers were at #EspaiCiència from the saló de l'ensenyament! 70+ students explored how the combination of light-emitting implants and photocontrolled drugs can revolutionize the treatment of pain & epilepsy
#photopharmacology #IBEC
🎙️ #PHOTOTHERAPORT coordinator and #IBEC researcher Pau Gorostiza shared his experience as a grant recipient at an EIC Pathfinder Open workshop💡🚀
His participation provided insights on the writing process and key strategies to prepare successful proposals for the upcoming 2025 call🙌
What does #PHOTOTHERAPORT proposes?
💡 PhotoTheraPorts: Tiny implants that emit visible light inside the body.
💊 Photoswitchable drugs: Activated only by specific wavelengths for targeted action.
This means precise neuromodulation with reduced systemic side effects.
📢💡 What if we could treat neuropathic pain & epilepsy with light?
In #PHOTOTHERAPORT, we’re developing light-emitting implants & light-controlled drugs for precise, side-effect-free treatments!
🚀 Funded by EU | Learn more: phototheraport.org
🧠 For #BrainAwarenessWeek we’re excited to present the #PHOTOTHERAPORT EU project!
🇪🇺 8 leading research institutions in Europe are collaborating to develop light-controlled drugs that modulate neuronal activity locally & on-demand without systemic side effects! 💡🔬
🧠💡 The study on Azocarnil - a photoswitchable analogue of the GABAA agonist-potentiator Abecarnil, led by #IBEC, has been selected by the Editorial Board of SYNFACTS for its important insights!
👉 www.thieme-connect.com/products/ejo...
This study is part of EU projects #PHOTOTHERAPORT and #DEEPER
